Benzodiazepine Dose Equivalency: 2 mg Diazepam (Valium)
2 mg of diazepam (Valium) is equivalent to approximately 0.1 mg of clonazepam (Klonopin) or 0.2 mg of alprazolam (Xanax).
Dose Conversion Based on Current Guidelines
According to the most recent 2025 Joint Clinical Practice Guideline on Benzodiazepine Tapering, the standard diazepam equivalency conversions are 1:
- 10 mg diazepam = 0.5 mg clonazepam
- 10 mg diazepam = 1 mg alprazolam
Therefore, for 2 mg diazepam:
- Clonazepam: 0.1 mg (2 mg ÷ 10 × 0.5 mg)
- Alprazolam: 0.2 mg (2 mg ÷ 10 × 1 mg)
Important Clinical Caveats
Conversion Inexactness
The guideline explicitly emphasizes that benzodiazepine dose equivalency is inexact and varies across patients 1. These conversions were established based on average doses where patients reported similar symptom management, not on precise pharmacological measurements. Unlike opioid conversions, no precise strategies exist for benzodiazepine conversion 1.
Patient-Specific Factors to Consider
When converting between benzodiazepines, you must account for:
- Age: Older adults have reduced hepatic metabolism and increased CNS sensitivity, requiring lower doses 1
- Liver function: All three medications are hepatically metabolized; hepatic impairment significantly affects dosing 1, 2
- Concurrent medications: Drug interactions alter pharmacokinetics 1
- Individual metabolism: Some patients require higher or lower doses than the reported equivalent 1
Transition Strategy
If converting from diazepam to clonazepam or alprazolam, transition slowly over 1-2 weeks rather than 1-2 days 1. This gradual transition allows for dose adjustment based on patient response and minimizes withdrawal symptoms.
Special Considerations for Alprazolam
Alprazolam is particularly challenging due to its short half-life and lack of active metabolites 1. Research suggests alprazolam may have higher reinforcing properties and abuse liability compared to diazepam 3. The FDA label indicates alprazolam dosing typically ranges from 0.25-4 mg daily for anxiety 2.
Monitoring During Conversion
After conversion, closely monitor for:
- Withdrawal symptoms: Anxiety, insomnia, tremor, seizures (rare but serious)
- Over-sedation: Drowsiness, cognitive impairment, falls risk
- Therapeutic response: Whether the equivalent dose provides adequate symptom control
If significant withdrawal symptoms emerge during conversion, transition the patient back to the original benzodiazepine 1.
Practical Application
For a patient taking 2 mg diazepam who needs conversion:
- Start with 0.1 mg clonazepam OR 0.2 mg alprazolam
- Transition gradually over 1-2 weeks
- Adjust based on patient experience—some may need slightly higher or lower doses
- In older adults or those with hepatic impairment, consider starting even lower